Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Pharmaceutical ETF May Be Back In Play ($PPH)

|Includes:VanEck Vectors Pharmaceutical ETF (PPH)

Stocks shrugged off early losses to close near session highs on heavier trade. All five major indices closed higher with high beta issues leading the advance. The small-cap Russell 2000 came storming back yesterday to erase virtually all of this week's losses. By the closing bell the Russell had added 1.5%. The S&P MidCap 400 climbed 0.9%, while the Nasdaq posted a 0.8% gain. Both the S&P 500 and the Dow Jones Industrial Average finished higher by 0.4%. The telecommunications and construction sectors were the day's big winners, while airlines and food retailers/wholesalers saw the biggest declines.

Market internals were bullish across the board yesterday. Volume climbed on the Nasdaq by 2.7% and on the NYSE by 5.2%. Advancing volume overpowered declining volume by a ratio of 2.2 to 1 on the NYSE and 2.6 t 1 on the Nasdaq. Yesterday was a big day for market bulls as it was a clear accumulation day. The higher volume suggests institutional investors were active in the market yesterday.

Yesterday, the Market Vectors Pharmaceuticals ETF (NYSEARCA:PPH) reversed sharply off of its 20-day EMA and is now poised to break out of its recent trading range. A volume propelled move above the February 21st high of $37.20 could provide a buy entry trigger for this ETF. We are placing PPH back on the watchlist. Trade details are provided to our members in the watchlist segment of the newsletter.

The iShares Dow Jones US Basic Materials Sector ETF (NYSEARCA:IYM) formed a bullish reversal candle yesterday, as it undercut its 10-day moving average...(continued in Wagner Daily newsletter).

The commentary above is an abbreviated version of The Wagner Daily, a daily ETF and stock swing trading newsletter. Subscribers to the full version also receive detailed entry and exit prices for potential swing trade entries, and an additional section dedicated to individual stock trades. To learn more about our trading strategy, please visit our blog.

Deron Wagner is a professional hedge fund manager who founded Morpheus Trading Group, a swing trader education firm, in 2002. He is the author of the best-selling book, Trading ETFs: Gaining An Edge With Technical Analysis. His new book, Advanced Technical Analysis of ETFs, will be released in August 2012. Past television appearances include CNBC, ABC, and Yahoo! FinanceVision. Wagner is also a frequent guest speaker at various trading events around the world, and can be reached by sending e-mail to: deron@morpheustrading.com.

DISCLAIMER: There is a risk for substantial losses trading securities and commodities. This material is for information purposes only and should not be construed as an offer or solicitation of an offer to buy or sell any securities. Morpheus Trading, LLC (hereinafter "The Company") is not a licensed broker, broker-dealer, market maker, investment banker, investment advisor, analyst or underwriter. This discussion contains forward-looking statements that involve risks and uncertainties. A stock's actual results could differ materially from descriptions given. The companies discussed in this report have not approved any statements made by The Company. Please consult a broker or financial planner before purchasing or selling any securities discussed in The Wagner Daily (hereinafter "The Newsletter"). The Company has not been compensated by any of the companies listed herein, or by their affiliates, agents, officers or employees for the preparation and distribution of any materials in The Newsletter. The Company and/or its affiliates, officers, directors and employees may or may not buy, sell or have positions in the securities discussed in The Newsletter and may profit in the event the shares of the companies discussed in The Newsletter rise or fall in value. Past performance never guarantees future results.

© 2002-2012 Morpheus Trading, LLC
Reproduction without permission is strictly prohibited.

Stocks: PPH